Know your Journal- The IHOPE Journal of Ophthalmology Ft. Dr. Raja Narayanan (Editor in Chief)

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-10-11 05:45 GMT | Update On 2025-07-28 05:40 GMT

The IHOPE Journal of Ophthalmology (IHOPEJO) publishes unique research and findings pertaining to big data analysis, health economics, and clinical, and public health research in eye health that enhance the science of ophthalmology. The Indian Health Outcomes, Public Health and Economics Research Centre (IHOPE), India, owns the journal, which is published by Scientific Scholar.

According to the goal of the IHOPE Centre, the IHOPE Journal of Ophthalmology (IHOPEJO) would encompass extensive clinical trials, public health, and health economics. It will cover a wide range of ophthalmology topics.

It is an international peer-reviewed publication that uses a double-blind review procedure. The paper is published once it has been accepted after peer review and is published on a quarterly basis. The journal is distributed electronically.

The journal has the following abstracting partners registered:

CrossRef, ReadCube, ProQuest, Google Scholar, and Portico.

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Know your Journal- The IHOPE Journal of Ophthalmology Ft. Dr. Raja Narayanan (Editor in Chief)

Similar News

AI-Powered Eye Scan Predicts Dementia Risk Years Before Symptoms: Study Finds

Omega-3-Rich Diet Help Protect Children Against Nearsightedness: Study Finds

Can Just an Hour of Scrolling Reels Lead to Eye Strain? Study Provides Insights

Surgical Implant Slows Vision Loss in Rare Eye Disease: NEJM Evidence Study

WHO Issues Safety Over Rare Eye Disorder from Semaglutide Use

Diabetes and Weight-Loss Drug Semaglutide Linked to Rare Eye Condition: European Medical Agency

Fear of Vision Loss May Delay Cataract Surgery: Study Finds

BRESER Study Demonstrates Real-World Efficacy and Safety of Lupin's Ranibizumab Biosimilar (Ranieyes)